News | Computed Tomography (CT) | January 30, 2023

Photon-counting detector CT reduces the amount of contrast needed for CT angiography (CTA) while maintaining image quality, according to a new study published in Radiology: Cardiothoracic Imaging, a journal of the Radiological Society of North America (RSNA). 

Comparison of image quality between EID CT with standard contrast media protocol and PCD CT with low-volume contrast media protocol using a matched radiation dose. Transverse and three-dimensional cinematic rendered images from thoracoabdominal CTA in a 71-year-old woman in group 2 are shown. (A–C) Images from third-generation EID CT with automated tube voltage selection of 90 kVp. (D–F) Images from PCD CT with reduced contrast media volume of 52.5 mL and VMI at 50 keV. Time interval between scans was 6 mon

Comparison of image quality between EID CT with standard contrast media protocol and PCD CT with low-volume contrast media protocol using a matched radiation dose. Transverse and three-dimensional cinematic rendered images from thoracoabdominal CTA in a 71-year-old woman in group 2 are shown. (A–C) Images from third-generation EID CT with automated tube voltage selection of 90 kVp. (D–F) Images from PCD CT with reduced contrast media volume of 52.5 mL and VMI at 50 keV. Time interval between scans was 6 months. CTA = CT angiography, EID = energy-integrating detector, PCD = photon-counting detector, VMI = virtual monoenergetic images. Image courtesy of Radiological Society of North America 

 


January 30, 2023 — Photon-counting detector CT reduces the amount of contrast needed for CT angiography (CTA) while maintaining image quality, according to a new study published today, January 26, in Radiology: Cardiothoracic Imaging, a journal of the Radiological Society of North America (RSNA). 

The portion of the aorta that passes through the chest and abdomen is prone to aneurysms. Risk increases with age. Doctors use CTA with contrast media to examine this region of the artery. While the iodinated contrast media used in these exams is considered very safe, there is a higher risk of adverse reactions in patients with kidney disease, or nephropathy. 

“Many patients undergoing CTA of the aorta are elderly, and some may suffer from a certain degree of nephropathy,” said senior author Hatem Alkadhi, M.D., M.P.H., from the Department of Diagnostic and Interventional Radiology at University Hospital Zurich in Zurich, Switzerland. “Thus, they might be at risk for a further reduction of their kidney function due to contrast media administration.” 

Using less contrast media is also good for the environment, as iodine breakdown products have harmful environmental effects. In addition, the supply of contrast media has suffered from shortages due to COVID-19-related disruptions in the pharmaceutical supply chain. 

Photon-counting detector CT is a new technology that can acquire high-quality images at lower contrast media volume than conventional CT scanners that rely on energy-integrating detectors. It also offers diagnostic quality images at lower radiation dose than those of conventional CT. 

Dr. Alkadhi and his University Hospital colleague Kai Higashigaito, M.D., led a study that looked at a low-volume contrast media protocol with photon-counting detector CT for CTA of the aorta in the chest and abdomen. 

The study included 100 people, mean age 75. Patients underwent CTA with photon-counting detector CT of the aorta in the chest and abdomen. The patients had received a previous CTA with conventional CT at equal radiation doses. 

Photon-counting CT had a higher contrast-to-noise ratio, a key measure of image quality, which translates to a low-volume contrast media protocol. Contrast media volume was reduced by 25%. 

Two independent readers rated the image quality of photon-counting CT as higher than that of conventional CT at an equal radiation dose. 

“We showed that the improved image quality of CTA with photon-counting detector CT systems can be used to reduce the amount of administered contrast media to the patients, without reducing the diagnostic yield of the examination,” Dr. Alkadhi said. “Image quality remained at the same level as that of previous CT angiography examinations in the same patients using a conventional CT, despite the fact that we reduced the contrast media volume.” 

Based on the positive results of the study, Dr. Alkadhi and his colleagues have changed their clinical routine. They now adjust the contrast media protocols in patients undergoing CTA of the aorta in the chest and abdomen. 

Besides its superior image quality and spatial resolution, photon-counting CT can provide detailed studies of tissue through its spectral imaging capability. Researchers are looking at this as a way to improve studies of the coronary arteries and the heart muscle. 

“Based on the initial experience with this new exciting technology, I envision that this detector type will become the standard in CT scanners in the near future,” Dr. Alkadhi said. 

For more information: www.rsna.org 


Related Content

News | FDA

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...

Time April 20, 2026
arrow
News | Radiology Imaging

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...

Time April 09, 2026
arrow
News | SNMMI

The Society of Nuclear Medicine and Molecular Imaging's (SNMMI) 2026 Annual Meeting will take place May 30–June 2 in Los ...

Time April 07, 2026
arrow
News | Radiology Business

March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...

Time March 31, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Cardiac Imaging

March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Time March 30, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 25, 2026 A Penn Medicine–led team has developed a first‑of‑its‑kind artificial intelligence system that interprets ...

Time March 26, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
News | Radiology Imaging

March 23, 2026 — Samsung Medison hsa announced that its U.S. medical imaging businesses, previously operating as ...

Time March 23, 2026
arrow
News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
Subscribe Now